Acute Exercise on Neurocognitive Function Among Adults With/Without Generic Risk of AD
Alzheimer Disease 2 Due to Apoe4 Isoform
About this trial
This is an interventional treatment trial for Alzheimer Disease 2 Due to Apoe4 Isoform focused on measuring aerobic exercise, APOE genotype, event-related potential, executive function, exercise prescription
Eligibility Criteria
Inclusion Criteria:
- Adults aged between 50 and 70 years old
- Normal or corrected-to-normal vision based on the minimal 20/20 standard
- Cognitively normal as mini-mental state examination scores (MMSE) > 26
Exclusion Criteria:
- Neurological or psychiatric disorders
- Cardiovascular disease
- Risk of cardiovascular fitness assessment based on the Physical Activity Readiness Questionnaire (PAR-Q)
- Red-green color blindness.
Sites / Locations
- Department of Physical Education and Sport Sciences, National Taiwan Normal University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
No Intervention
Low-intensity with longer duration (40-min) exercise (LI-40)
Moderate-intensity with 30 min exercise (MI-30)
High-intensity with shorter duration (16-min) exercise (HI-16)
Control treatment (CON)
The participants were instructed to complete a volume-matched low-intensity with longer duration (40-min) exercise (LI-40) treatment.
The participants were instructed to complete a volume-matched moderate-intensity with 30 min exercise (MI-30) treatment.
The participants were instructed to complete a volume-matched high-intensity with shorter duration (16-min) exercise (HI-16) treatment.
The participants in the control treatment (CON) were instructed to complete book reading for 30-min.